benazepril
{{Short description|Medication used to treat high blood pressure and heart failure}}
{{Use dmy dates|date=October 2022}}
{{cs1 config |name-list-style=vanc |display-authors=6}}
{{Infobox drug
| verifiedrevid = 459529583
| image = Benazepril structure.svg
| alt =
| caption =
| image2 = Benazepril-3D-balls.png
| alt2 =
| pronounce = {{IPAc-en|b|ə|ˈ|n|æ|z|ə|p|r|ɪ|l}}
| tradename = Lotensin, others
| Drugs.com = {{drugs.com|monograph|benazepril-hydrochloride}}
| MedlinePlus = a692011
| DailyMedID = Benazepril
| pregnancy_AU =
| pregnancy_AU_comment =
| pregnancy_category =
| routes_of_administration = By mouth
| class =
| ATC_prefix = C09
| ATC_suffix = AA07
| ATC_supplemental =
| legal_AU =
| legal_AU_comment =
| legal_BR =
| legal_BR_comment =
| legal_CA =
| legal_CA_comment =
| legal_DE =
| legal_DE_comment =
| legal_NZ =
| legal_NZ_comment =
| legal_UK =
| legal_UK_comment =
| legal_US = Rx-only
| legal_EU =
| legal_EU_comment =
| legal_UN =
| legal_UN_comment =
| legal_status = Rx-only
| bioavailability =
| protein_bound = 96.7%
| metabolism = Liver glucuronidation
| metabolites =
| onset =
| elimination_half-life = 10-11 hours
| duration_of_action =
| excretion = Kidney and bile duct
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 86541-75-5
| CAS_supplemental =
| PubChem = 5362124
| IUPHAR_ligand = 6374
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB00542
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 4514935
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = UDM7Q7QWP8
| KEGG = D07499
| KEGG2 = D00620
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 3011
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 838
| NIAID_ChemDB =
| PDB_ligand =
| synonyms =
| IUPAC_name = 2-[(3S)-3-
| C = 24
| H = 28
| N = 2
| O = 5
| SMILES = O=C(OCC)[C@@H](N[C@@H]2C(=O)N(c1ccccc1CC2)CC(=O)O)CCc3ccccc3
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C24H28N2O5/c1-2-31-24(30)20(14-12-17-8-4-3-5-9-17)25-19-15-13-18-10-6-7-11-21(18)26(23(19)29)16-22(27)28/h3-11,19-20,25H,2,12-16H2,1H3,(H,27,28)/t19-,20-/m0/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI_comment =
| StdInChIKey = XPCFTKFZXHTYIP-PMACEKPBSA-N
| density =
| density_notes =
| melting_point =
| melting_high =
| melting_notes =
| boiling_point =
| boiling_notes =
| solubility =
| sol_units =
| specific_rotation =
}}
Benazepril, sold under the brand name Lotensin among others, is a medication used to treat high blood pressure, heart failure, and diabetic kidney disease. It is a reasonable initial treatment for high blood pressure. It is taken by mouth. Versions are available as the combinations benazepril/hydrochlorothiazide and benazepril/amlodipine.
Common side effects include feeling tired, dizziness, cough, and light-headedness with standing. Serious side effects may include kidney problems, low blood pressure, high blood potassium, and angioedema. Use in pregnancy may harm the baby, while use when breastfeeding may be safe.{{cite web |title=Benazepril Pregnancy and Breastfeeding Warnings |url=https://www.drugs.com/pregnancy/benazepril.html |website=Drugs.com |access-date=3 March 2019 }} It is an ACE inhibitor and works by decreasing renin-angiotensin-aldosterone system activity.{{cite web |title=Benazepril Hydrochloride Monograph for Professionals |url=https://www.drugs.com/monograph/benazepril-hydrochloride.html |website=Drugs.com |publisher=American Society of Health-System Pharmacists |access-date=3 March 2019 }}
Benazepril was patented in 1981 and came into medical use in 1990. It is available as a generic medication. In 2022, it was the 159th most commonly prescribed medication in the United States, with more than 3{{nbsp}}million prescriptions.{{cite web | title=The Top 300 of 2022 | url=https://clincalc.com/DrugStats/Top300Drugs.aspx | website=ClinCalc | access-date=30 August 2024 | archive-date=30 August 2024 | archive-url=https://web.archive.org/web/20240830202410/https://clincalc.com/DrugStats/Top300Drugs.aspx | url-status=live }}{{cite web | title = Benazepril Drug Usage Statistics, United States, 2013 - 2022 | website = ClinCalc | url = https://clincalc.com/DrugStats/Drugs/Benazepril | access-date = 30 August 2024 }}
Medical uses
Lotensin is indicated for the treatment of hypertension, to lower blood pressure.
Side effects
The most common side effects patients experience are a headache or a chronic cough. The chronic cough develops in about 20% of people treated.{{cite web |url= http://www.medscape.com/viewarticle/484537_2 | vauthors = Dykewicz MS | title=Cough and Angioedema From Angiotensin-Converting Enzyme Inhibitors: New Insights Into Mechanisms and Management|work=Medscape|date=April 2004 |access-date=2 April 2014}}
Contraindications
Dosage forms
It is also available in combination with hydrochlorothiazide, under the brand name Lotensin HCT, and with amlodipine (Lotrel).
Veterinary uses
File:Veterinary benazepril.jpg
Under the brand names Fortekor (Novartis){{Cite web |title=Fortekor Flavor Tabs (5 mg) for Animal Use (Canada) |url=https://www.drugs.com/vet/fortekor-flavor-tabs-5-mg-can.html |access-date=2024-06-03 |website=Drugs.com |language=en}} and VetACE (Jurox Animal Health),{{Cite web |title=VetACE® - Jurox |url=https://www.jurox.com.au/product/vetace/ |access-date=2024-06-03 |website=www.jurox.com.au |language=en-AU}} benazepril is used to treat congestive heart failure in dogs{{cite journal | vauthors = King JN, Mauron C, Kaiser G | title = Pharmacokinetics of the active metabolite of benazepril, benazeprilat, and inhibition of plasma angiotensin-converting enzyme activity after single and repeated administrations to dogs | journal = American Journal of Veterinary Research | volume = 56 | issue = 12 | pages = 1620–1628 | date = December 1995 | doi = 10.2460/ajvr.1995.56.12.1620 | pmid = 8599524 }}{{cite journal | vauthors = O'Grady MR, O'Sullivan ML, Minors SL, Horne R | title = Efficacy of benazepril hydrochloride to delay the progression of occult dilated cardiomyopathy in Doberman Pinschers | journal = Journal of Veterinary Internal Medicine | volume = 23 | issue = 5 | pages = 977–983 | year = 2009 | pmid = 19572914 | doi = 10.1111/j.1939-1676.2009.0346.x | doi-access = free }} and chronic kidney failure in cats and dogs.{{Cite web|title=Fortekor Flavor Tabs (5 mg) (Canada) for Animal Use|url=https://www.drugs.com/vet/fortekor-flavor-tabs-5-mg-can.html|access-date=9 December 2020|website=Drugs.com}}
{{clear-left}}
References
{{reflist}}
{{ACE inhibitors}}
{{Angiotensin receptor modulators}}
{{Portal bar | Medicine}}
{{Authority control}}